Erratum: Epigenetic control of metastasis-associated protein 1 gene expression by hepatitis B virus X protein during hepatocarcinogenesis (Oncogenesis (2012) 1 (e25) DOI:10.1038/oncsis.2012.26);Epigenetic control of metastasis-associated protein 1 gene expression by hepatitis B virus X protein during hepatocarcinogenesis

Oncogenesis

Volumn 1, Issue 9, 2012, Pages

  Lee, M H ^a   Na, H ^a   Na, T Y ^a   Shin, Y K ^a   Seong, J K ^a   Lee, M O ^a  

^a Seoul National University   (South Korea)

Author keywords

DNA methylation; HBx; MTA1; p53

Indexed keywords

EID: 84868275674     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2014.4     Document Type: Erratum

References (43)

1. Neuveut C, Wei Y, Buendia MA. Mechanisms of HBV-related hepatocarcinogenesis. J Hepatol 2010; 52: 594-604.
2. Zhang X, Zhang H, Ye L. Effects of hepatitis B virus X protein on the development of liver cancer. J Lab Clin Med 2006; 147: 58-66. (Pubitemid 43188997)
3. Lara-Pezzi E, Serrador JM, Montoya MC, Zamora D, Yáñez- Mó M, Carretero M et al. The hepatitis B virus X protein (HBx) induces a migratory phenotype in a CD44-dependent manner: possible role of HBx in invasion and metastasis. Hepatology 2001; 33: 1270-1281. (Pubitemid 32378227)
4. Ou DP, Tao YM, Tang FQ, Yang LY. The hepatitis B virus X protein promotes hepatocellular carcinoma metastasis by upregulation of matrix metalloproteinases. Int J Cancer 2007; 15: 1208-1214.
5. Zhang X, Liu S, Hu T, Liu S, He Y, Sun S. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 2009; 50: 490-499.
6. Moon WS, Chang K, Tarnawski AS. Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: Relationship to vascular invasion and estrogen receptor-alpha. Hum Pathol 2004; 35: 424-429. (Pubitemid 38507078)
7. Ryu SH, Chung YH, Lee H, Kim JA, Shin HD, Min HJ et al. Metastatic tumor antigen is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma. Hepatology 2008; 47: 929-936. (Pubitemid 351449684)
8. Yoo YG, Na TY, Seo HW, Seong JK, Park CK, Shin YK et al. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 2008; 27: 3405-3413. (Pubitemid 351769313)
9. Bui-Nguyen TM, Pakala SB, Sirigiri RD, Xia W, Hung MC, Sarin SK et al. NF-kappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx. Oncogene 2010; 29: 1179-1189.
10. Bui-Nguyen TM, Pakala SB, Sirigiri DR, Martin E, Murad F, Kumar R. Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator. J Biol Chem 2010; 285: 6980-6986.
11. Taby R, Issa JP. Cancer epigenetics. CA Cancer J Clin 2010; 60: 376-392.
12. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006; 3: 89-97. (Pubitemid 43221841)
13. Tischoff I, Tannapfe A. DNA methylation in hepatocellular carcinoma. World J Gastroenterol 2008; 14: 1741-1748. (Pubitemid 351493380)
14. Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Hepatology 2002; 36: 692-701. (Pubitemid 34977181)
15. Yamada S, Nomoto S, Fujii T, Takeda S, Kanazumi N, Sugimoto H et al. Frequent promoter methylation of M-cadherin in hepatocellular carcinoma is associated with poor prognosis. Anticancer Res 2007; 27: 2269-2274. (Pubitemid 47228063)
16. Wong CM, Ng YL, Lee JM, Wong CC, Cheung OF, Chan CY et al. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. Hepatology 2007; 45: 1129-1138. (Pubitemid 46775774)
17. Lee JO, Kwun HJ, Jung JK, Choi KH, Min DS, Jang KL. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 2005; 24: 6617-6625. (Pubitemid 41486792)
18. Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH et al. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 2007; 132: 1476-1494. (Pubitemid 46627570)
19. Zhu YZ, Zhu R, Fan J, Pan Q, Li H, Chen Q et al. Hepatitis B virus X protein induces hypermethylation of p16(INK4A) promoter via DNA methyltransferases in the early stage of HBV-associated hepatocarcinogenesis. J Viral Hepat 2010; 17: 98-107.
20. Jung JK, Park SH, Jang KL. Hepatitis B virus X protein overcomes the growthinhibitory potential of retinoic acid by downregulating retinoic acid receptorbeta2 expression via DNA methylation. J Gen Virol 2010; 91: 493-500.
21. Zhao J, Wu G, Bu F, Lu B, Liang A, Cao L et al. Epigenetic silence of ankyrin-repeatcontaining, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma. Hepatology 2010; 51: 142-153.
22. Yoo YG, Oh SH, Park ES, Cho H, Lee N, Park H et al. Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway. J Biol Chem 2003; 278: 39076-39084. (Pubitemid 37221811)
23. Lee M-H, Na H, Kim E-J, Lee H-W, Lee M-O. Poly(ADP-ribosyl)ation of p53 induces gene-specific transcriptional repression of MTA1. Oncogene (e-pub ahead of print January 2012; doi:10.1038/onc.2012.2).
24. Nabilsi NH, Broaddus RR, Loose DS. DNA methylation inhibits p53-mediated survivin repression. Oncogene 2009; 28: 2046-2050.
25. Lee SG, Rho HM. Transcriptional repression of the human p53 gene by hepatitis B viral X protein. Oncogene 2000; 19: 468-471. (Pubitemid 30077349)
26. Na TY, Shin YK, Roh KJ, Kang SA, Hong I, Oh SJ et al. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma. Hepatology 2009; 49: 1122-1131.
27. Saito Y, Kanai Y, Nakagawa T, Sakamoto M, Saito H, Ishii H et al. Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer 2003; 105: 527-532. (Pubitemid 36578558)
28. Park HJ, Yu E, Shim YH. DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma. Cancer Lett 2006; 233: 271-278. (Pubitemid 43327383)
29. Renaud S, Loukinov D, Abdullaev Z, Guilleret I, Bosman FT, Lobanenkov V et al. Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene. Nucleic Acids Res 2007; 35: 1245-1256. (Pubitemid 46522976)
30. Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, Parant JM et al. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 2004; 119: 861-872. (Pubitemid 40017691)
31. Lewis BC, Klimstra DS, Socci ND, Xu S, Koutcher A, Varmus HE. The absence of p53 promotes metastasis in a novel somatic mouse model for hepatocellular carcinoma. Mol Cell Biol 2005; 25: 1228-1237. (Pubitemid 40204903)
32. Cougot D, Neuveut C, Buendia MA. HBV induced carcinogenesis. J Clin Virol 2005; 34: S75-S78.
33. Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP et al. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci USA 1997; 94: 14707-14712. (Pubitemid 28041438)
34. Hussain SP, Schwank J, Staib F, Wang XW, Harris CC. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 2007; 26: 2166-2176. (Pubitemid 46536641)
35. Zhang X, Dong N, Yin L, Cai N, Ma H, You J et al. Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues. J Med Virol 2005; 77: 374-381. (Pubitemid 41395868)
36. Zardo G, Caiafa P. The unmethylated state of CpG islands in mouse fibroblasts depends on the poly(ADP-ribosyl)ation process. J Biol Chem 1998; 273: 16517-165120.
37. Zardo G, Marenzi S, Perilli M, Caiafa P. Inhibition of poly(ADP-ribosyl)ation introduces an anomalous methylation pattern in transfected foreign DNA. FASEB J 1999; 13: 1518-1522. (Pubitemid 29411784)
38. Qian H, Yu J, Li Y, Wang H, Song C, Zhang X et al. RNA interference of metastasisassociated gene 1 inhibits metastasis of B16F10 melanoma cells in a C57BL/6 mouse model. Biol Cell 2007; 99: 573-581. (Pubitemid 47543315)
39. Rao Y, Wang H, Fan L, Chen G. Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/b-catenin complex. J Huazhong Univ Sci Technolog Med Sci 2011; 31: 1-9.
40. Kai L, Wang J, Ivanovic M, Chung YT, Laskin WB, Schulze-Hoepfner F et al. Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1). Prostate 2011; 71: 268-280.
41. Herceg Z, Paliwal A. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome. Mutat Res 2011; 727: 55-61.
42. Kanda T, Tada M, Imazeki F, Yokosuka O, Nagao K, Saisho H. 5-aza-20-deoxycytidine sensitizes hepatoma and pancreatic cancer cell lines. Oncol Rep 2005; 14: 975-979.
43. Kim MS, Kondo T, Takada I, Youn MY, Yamamoto Y, Takahashi S et al. DNA demethylation in hormone-induced transcriptional derepression. Nature 2009; 461: 1007-1012.